Stocklytics Platform
Asset logo for symbol ABT
Abbott Laboratories
ABT61
$131.41arrow_drop_down0.08%-$0.11
S&P500
Asset logo for symbol ABT
ABT61

$131.41

arrow_drop_down0.08%

Income Statement (ABT)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
EBIT$2.18B$2.10B$1.83B$1.53B$2.05B
EBITDA$2.98B$2.90B$2.63B$2.34B$2.87B
gross Profit$6.03B$5.93B$5.80B$5.54B$5.25B
NET Income$9.22B$1.64B$1.30B$1.22B$1.59B
total Revenue$10.97B$10.63B$10.37B$9.96B$10.24B

Balance Sheet (ABT)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
cash Equivalents-----
net Debt$7.40B$7.42B$7.76B$8.30B$8.97B
stockholders Equity$47.66B$39.79B$39.31B$38.81B$38.60B
total Assets$81.41B$74.35B$73.01B$72.46B$73.21B
total Debt$15.02B$14.97B$14.75B$14.58B$15.87B
total Liabilities$33.51B$34.32B$33.45B$33.42B$34.38B

Cash Flow (ABT)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
financing Cash Flow-$1.86B-$1.57B-$791.00M-$1.17B-$2.05B
free Cash Flow$2.14B$2.14B$1.42B$627.00M$2.28B
investing Cash Flow-----
operating Cash Flow$2.86B$2.70B$1.96B$1.02B$3.03B

Abbott Laboratories (ABT) Financials

Abbott Laboratories (ABT) is a multinational healthcare company that develops, manufactures, and sells a wide range of healthcare products. The company's income statement provides a snapshot of its financial performance over a specific period of time. It lists the company's revenues, expenses, and net income. Revenues represent the total amount of money generated from the sale of goods or services. Expenses include costs such as production costs, selling and administrative expenses, and taxes. Net income is the company's total revenue minus expenses and taxes. In recent years, Abbott Laboratories has consistently reported strong financial performance, with increasing revenues and net income.
One important measure of a company's profitability is its Earnings Before Interest and Taxes (EBIT). EBIT represents a company's operating income before deducting interest and taxes. It provides a measure of a company's ability to generate profits from its operations. Abbott Laboratories' EBIT has been steadily increasing over the years, reflecting the company's strong financial performance. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is another measure of a company's profitability. It provides a more comprehensive view of a company's profitability by excluding non-cash expenses such as depreciation and amortization. Abbott Laboratories has consistently reported solid EBITDA figures, indicating its ability to generate substantial cash flow from its operations.
add Abbott Laboratories to watchlist

Keep an eye on Abbott Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level